Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page shows Revision: v3.5.4, replacing the previous v3.5.3, indicating a software/version update to the page rendering. This update is an internal maintenance change rather than a modification to the study text or data.
    Difference
    0.1%
    Check dated 2026-05-15T03:09:12.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    34 days ago
    Change Detected
    Summary
    A new revision tag v3.5.3 is added, replacing the previous v3.5.2. This reflects a minor update to the page's revision/version information.
    Difference
    0.1%
    Check dated 2026-04-30T17:27:07.000Z thumbnail image
  6. Check
    48 days ago
    Change Detected
    Summary
    Footer now shows Revision: v3.5.2, replacing Revision: v3.5.0. This is a technical update with no impact on study information or user actions.
    Difference
    0.1%
    Check dated 2026-04-16T10:58:22.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a listed condition in the study details.
    Difference
    0.1%
    Check dated 2026-04-02T04:47:37.000Z thumbnail image
  8. Check
    77 days ago
    Change Detected
    Summary
    Revision v3.5.0 added; revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:52:23.000Z thumbnail image
  9. Check
    84 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:02.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.